BIMI 0.3 mg/ml EYE DROPS SOLUTION

2. What you need to know before you use Bimi

Do not use Bimi

• If you are allergic to bimatoprost or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before you start using this medicine, if:

• you have any respiratory problems
• you have liver or kidney problems
• you have had cataract surgery in the past
• you have low blood pressure or a slow heart rate
• you have had a viral infection or inflammation of the eye
• you use contact lenses (see section 3)

During treatment, Bimi may cause fat loss around the eye that can cause deepening of the eyelid sulcus, sinking of the eyes (enophthalmos), drooping of the eyelids (ptosis), stretching of the skin around the eye (involution of the dermatocalasis), and the white part of the eye becomes more visible (inferior scleral exposure). The changes are usually mild, but if they become more pronounced, they can affect your field of vision. The changes may disappear if you stop using Bimi.

Bimatoprost may also cause darkening and growth of the eyelashes, as well as darkening of the skin around the eyelid. The color of the iris may darken. These changes may be permanent and more visible if only one eye is being treated.

If you have a history of contact hypersensitivity to silver, you should not use this medicine.

Children and adolescents

This medicine has not been studied in patients under 18 years of age and should not be used in patients under 18 years of age.

Other medicines and Bimi

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

If you are using other eye drops, leave at least 5 minutes between the application of Bimi and the other eye drops. Ophthalmic ointments should be administered last.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

This medicine may pass into breast milk, so you should not use it if you are breastfeeding.

Driving and using machines

After instillation of bimatoprost, blurred vision may occur for a short time. Do not drive or use machines until your vision is clear.

Bimi contains phosphates

This medicine contains 0.95 mg of phosphates per milliliter. If you have severe damage to the clear layer on the front of the eye (the cornea), treatment with phosphates, in very rare cases, may cause cloudy patches on the cornea due to calcium.

3. How to use Bimi

Follow the instructions for administration of this medicine exactly as told by your doctor. If you are not sure, talk to your doctor or pharmacist.

This medicine should only be applied to the eyes. The recommended dose is one drop of bimatoprost once a day, at night, in each eye that needs treatment.

Bimatoprost has not been studied in patients who use contact lenses. Contact lenses should be removed before installation and may be reinserted 15 minutes after administration.

Do not use it more than once a day, as the effectiveness of the treatment may be reduced.

Bimi is a sterile solution that does not contain preservatives. See section 6, Appearance of Bimi and contents of the pack.

Before instilling the eye drops:

• When you first use it, before putting a drop in your eye, you should first practice using the dropper bottle by squeezing it slowly to release a drop in the air, away from your eye.
• When you are confident that you can put one drop in your eye, you should choose the position that is most comfortable for you to instill the drops (you can sit, lie on your back, or stand in front of a mirror).

Instructions for use:

1. Wash your hands carefully before using this medicine.
2. If the pack or bottle is damaged, do not use the medicine.
3. When you use the medicine for the first time, unscrew the cap after making sure that the tamper-evident ring on the cap has not been broken. You should feel a slight resistance until the tamper-evident ring breaks (see image 1).
4. If the tamper-evident ring is loose, discard it because it could fall into your eye and cause injury.
5. Tilt your head back and gently pull down the lower eyelid to form a pouch between your eye and the eyelid (see image 2). Avoid touching the tip of the bottle to your eye, eyelids, or fingers.
6. Instill one drop into the pouch by gently squeezing the bottle (see image 3). Squeeze the bottle gently in the middle and let one drop fall into your eye. There may be a delay of a few seconds between squeezing and the drop coming out. Do not squeeze too hard. If you are not sure how to administer your medicine, talk to your doctor, pharmacist, or nurse.
7. Press the tear duct for about 2 minutes (by pressing a finger against the corner of your eye next to your nose) and keep your eyes closed and closed for this time. This ensures that the drop is absorbed by the eye and that the amount of medicine that drains through the tear duct into the nose is probably reduced.
8. Repeat steps 5 and 6 in the other eye if your doctor has told you to do so.
9. After use and before closing, the bottle should be shaken once downwards, without touching the dropper tip, to remove any residual liquid from the tip. This is necessary to ensure the delivery of subsequent drops. After instillation, screw the cap back onto the bottle (see image 4).
10. Additional information for the bottle containing 9 ml of solution: At the end of the 90-day period of validity of the medicine after opening, a little Bimi will remain in the bottle. Do not attempt to use the remaining excess medicine in the bottle. Do not use the eye drops for more than 90 days after the first opening of the bottle.

If a drop misses your eye, try again.

image 1image 2image 3image 4

If you use more Bimi than you should

If you use more of this medicine than you should, it is unlikely to harm you. Apply the next dose at the usual time. If you are concerned, talk to your doctor or pharmacist.

In case of overdose or accidental ingestion, talk to your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.

If you forget to use Bimi

If you forget to apply this medicine, use one drop as soon as you remember and then go back to your usual routine. Do not apply a double dose to make up for the forgotten dose.

If you stop using Bimi

This medicine should be used every day for it to work well. If you stop using it, the pressure in your eye may increase, so talk to your doctor before stopping treatment.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience any side effect, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet.

Very common side effects

These may affect more than 1 in 10 people

Affecting the eye

• Mild redness (up to 24% of people)
• Fat loss in the eye area that can cause deepening of the eyelid sulcus, sinking of the eyes (enophthalmos), drooping of the eyelids (ptosis), stretching of the skin around the eye (involution of the dermatocalasis), and the white part of the eye becomes more visible (inferior scleral exposure).

Common side effects

These may affect up to 1 in 10 people

Affecting the eye

• Small erosions on the surface of the eye, with or without inflammation
• Irritation
• Itching in the eyes
• Pain
• Dryness
• Sensation of having something in the eye
• Longer eyelashes
• Darker skin around the eye
• Red eyelids

Uncommon side effects

These may affect up to 1 in 100 people

Affecting the eye

• Tired eyes
• Sensitivity to light
• Darker iris
• Inflamed and itchy eyelids
• Watery eyes
• Inflammation of the clear layer that covers the surface of the eye
• Blurred vision

Affecting the body

• Headaches
• Excessive hair growth around the eye

Rare side effects

Affecting the eye

• Sticky eyes
• Eye discomfort

Affecting the body

• Asthma
• Worsening of asthma
• Worsening of the lung disease called chronic obstructive pulmonary disease (COPD)
• Difficulty breathing
• Symptoms of an allergic reaction (inflammation, redness of the eye, and skin rash)
• Dizziness
• High blood pressure
• Discoloration of the skin (around the eye)

In addition to the side effects of bimatoprost 0.3 mg/ml single-dose, the following side effects have been observed with the multi-dose formulation with preservatives for bimatoprost 0.3 mg/ml and may occur in patients using bimatoprost 0.3 mg/ml single-dose:

• Burning sensation in the eye
• Allergic reaction in the eye
• Inflammation of the eyelid
• Difficulty seeing clearly
• Worsening of vision
• Darker eyelashes
• Retinal hemorrhage
• Inflammation inside the eye
• Cystoid macular edema (inflammation of the retina inside the eye that leads to worsening of vision)
• Inflammation of the iris
• Lid twitching
• The eyelid has contracted and separated from the surface of the eye
• Nausea
• Redness of the skin around the eye
• Weakness
• Increased values in some blood tests that indicate how the liver is working

Other side effects reported with eye drops that contain phosphates:

If you have severe damage to the clear layer on the front of the eye (the cornea), treatment with phosphates, in very rare cases, may cause cloudy patches on the cornea due to calcium.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Bimi

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the bottle after “EXP”. The expiry date is the last day of the month shown.

This medicine does not require any special storage conditions.

After opening the bottle for the first time, store for 90 days at a temperature below 25°C.

Discard 90 days after the first opening of the bottle.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Bimi

• The active substance is bimatoprost.

Each milliliter of solution contains 0.3 mg of bimatoprost.

Each drop contains approximately 0.0087 mg of bimatoprost.

Each bottle contains 3 ml or 9 ml of solution.

• The other ingredients are sodium hydrogen phosphate dodecahydrate, citric acid monohydrate, sodium chloride, hydrochloric acid diluted (for pH adjustment), water for injections.

Appearance of the product and contents of the pack

Bimi is a clear and colorless solution.

This medicine is available in a white LDPE bottle (5 ml or 11 ml) with a multidose dropper applicator made of HDPE, which prevents contamination of the contents due to a silicone valve system, air return filter to the bottle, and a tamper-evident HDPE screw cap, and a cardboard box.

Pack sizes: cartons containing 1 or 3 bottles of 3 ml of solution or 1 bottle of 9 ml of solution.

Not all pack sizes may be marketed.

Marketing authorization holder

BRILL PHARMA, S.L.

C/ Munner, 8

08022 Barcelona

Spain

Manufacturer

Rafarm S.A.

Thesi Pousi Xatzi Agiou Louka

Paiania, 190 02

Greece

Date of last revision of this package leaflet:July 2022

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)